Black Diamond Therapeutics, Inc. (BDTX) has 63 open-market insider trades by 14 insiders since 2020. The most active filer is Bradley J. Bolzon Ph.D., Director & 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Growth N. V. Biotech | 10% Owner | — | 7 | $30.6M | 2025-03-19 |
| Bradley J. Bolzon Ph.D. | Dir10% Owner | — | 15 | $28.1M | 2020-12-14 |
| Ali Behbahani | Dir | — | 2 | $20.2M | 2026-09-18 |
| Rajeev M. Shah | Dir | — | 1 | $19.0M | 2021-05-20 |
| Deerfield Partners, L.P. | 10% Owner | — | 1 | $7.6M | 2020-02-03 |
| Biotech Ag Bb | 10% Owner | — | 4 | $7.1M | 2023-06-30 |
| RA Capital Management, L.P. | Dir | — | 1 | $4.7M | 2023-07-05 |
| David M. Epstein | — | — | 4 | $1.5M | 2023-06-27 |
| Versant Voyageurs I Parallel, L.P. | 10% Owner | — | 1 | $1.4M | 2024-08-28 |
| Brent Hatzis-Schoch | — | — | 10 | $1.3M | 2025-01-30 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Growth N. V. Biotech | 10% Owner | Sell | $15.2M | 2025-03-19 |
| Versant Voyageurs I Parallel, L.P. | 10% Owner | Sell | $1.4M | 2024-08-28 |
| Growth N. V. Biotech | 10% Owner | Buy | $936K | 2023-10-17 |
| Ali Behbahani | Director | Buy | $5.0M | 2023-07-05 |
| RA Capital Management, L.P. | Director | Buy | $4.7M | 2023-07-05 |
| Biotech Ag Bb | 10% Owner | Buy | $5.0M |
Companies that share insiders with BDTX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2023-06-30 |
| Growth N. V. Biotech | 10% Owner | Buy | $9.6M | 2023-06-27 |
| David M. Epstein | — | Sell | $168K | 2023-06-27 |
| Fang Ni | SEE REMARKS | Buy | $72K | 2022-12-21 |
| Growth N. V. Biotech | 10% Owner | Buy | $449K | 2022-10-31 |
| Biotech Ag Bb | 10% Owner | Buy | $1.5M | 2022-10-27 |
| Biotech Ag Bb | 10% Owner | Buy | $265K | 2022-10-21 |
| Biotech Ag Bb | 10% Owner | Buy | $358K | 2022-10-19 |
| Fang Ni | — | Buy | $61K | 2022-06-29 |
| Growth N. V. Biotech | 10% Owner | Buy | $1.7M | 2022-04-27 |